Barrett’s Esophagus: a Discrepancy between Macroscopic and Histological Diagnosis

Background and Study Aims: The diagnosis of Barrett’s esophagus at present requires endoscopic and histological confirmation of specialized intestinal metaplasia. This study prospectively analyzed the endoscopic and histological prevalence of Barrett’s esophagus and the risk factors for the presence of Barrett’s esophagus among patients being treated in an endoscopy unit.
Patients and Methods: A total of 474 unselected patients (58 % men; mean age 52 y) were included in the study. Two biopsy specimens each were taken from below and above the squamocolumnar junction and from the antrum and gastric body. Four-quadrant biopsies were taken every 1 - 2 cm to confirm a macroscopic suspicion of Barrett’s esophagus.
Results: Barrett’s esophagus was suspected at endoscopy in 109 patients (23 %). Of the 109 patients with endoscopically suspected Barrett’s esophagus, only 46 (42 %) had the finding confirmed histologically. The sensitivity and specificity for the endoscopic diagnosis of Barrett’s esophagus were 62 % and 84 %, respectively. A multivariate logistic regression analysis identified age (P = 0.0001; odds ratio per life-year 1.087; 95 % CI, 1.046 - 1.139), male sex (P = 0.0020; OR 6.346; 95 % CI, 2.094 - 22.314), and the number of biopsies (P = 0.0025; OR 1.661; 95 % CI, 1.247 - 2.392) as factors associated with evidence of intestinal metaplasia on biopsy.
Conclusion: The striking discrepancy between the endoscopic findings and the histological diagnosis may be due to the focal distribution of intestinal metaplasia. This emphasizes the importance of an adequate biopsy protocol. In addition, better methods of detecting focal islands of intestinal metaplasia that are not visible at conventional endoscopy are needed.

References

• 1 Cameron A J, Ott B J, Payne W S. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus.  N Engl J Med. 1985;  313 857-859
• 2 Falk G W. Barrett’s esophagus.  Gastrointest Endosc Clin N Am. 1994;  4 773-789
• 3 Palley S L, Sampliner R E, Garewal H S. Management of high-grade dysplasia in Barrett’s esophagus.  J Clin Gastroenterol. 1989;  11 369-372
• 4 Spechler S J, Robbins A H, Rubins H B. et al . Adenocarcinoma and Barrett’s esophagus: an overrated risk?.  Gastroenterology. 1984;  87 927-933
• 5 Drewitz D J, Sampliner R E, Garewal H S. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years.  Am J Gastroenterol. 1997;  92 212-215
• 6 O’Connor J B, Falk G W, Richter J E. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry.  Am J Gastroenterol. 1999;  94 2037-2042
• 7 Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology.  Am J Gastroenterol. 2002;  97 1888-1895
• 8 Hirota W K, Loughney T M, Lazas D J. et al . Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.  Gastroenterology. 1999;  116 277-285
• 9 Nandurkar S, Talley N J, Martin C J. et al . Short segment Barrett’s oesophagus: prevalence, diagnosis and associations.  Gut. 1997;  40 710-715
• 10 Mueller J, Werner M, Stolte M. Barrett’s esophagus: histopathology, definitions and diagnostic criteria.  World J Surg. 2004;  28 148-154
• 11 Dixon M F, Genta R M, Yardley J H. et al . Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994.  Am J Surg Pathol. 1996;  20 1161-1181
• 12 Cameron A, Kamath P, Carpenter H. Barrett’s esophagus: the prevalence of short and long segments in reflux patients [abstract].  Gastroenterology. 1995;  91 A65
• 13 Weston A P, Krmpotich P, Makdisi W F. et al . Short segment Barrett’s esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.  Am J Gastroenterol. 1996;  91 981-986
• 14 Winters C  Jr, Spurling T J, Chobanian S J. et al . Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease.  Gastroenterology. 1987;  92 118-124
• 15 Eloubeidi M A, Provenzale D. Does this patient have Barrett’s esophagus? The utility of predicting Barrett’s esophagus at the index endoscopy.  Am J Gastroenterol. 1999;  94 937-943
• 16 Weinstein W, Leh W, Lewin K. et al . How often is short segment Barrett’s esophagus proven histologically? A prospective study [abstract].  Gastroenterology. 2002;  122 (Suppl) A293
• 17 Meining A, Ott R, Becker I. et al . The Munich Barrett follow-up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only - what is the clinical significance?.  Gut. 2004;  53 1402-1407
• 18 Ramnath G, Bampton P, Easterman A. A review of current surveillance practice for Barrett’s esophagus: a retrospective analysis of a tertiary hospital endoscopy database [abstract].  Gastrointest Endosc. 2002;  55 AB202
• 19 Sharma P, Topalovski M, Mayo M S. et al . Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 289-293
• 20 Canto M I, Setrakian S, Willis J. et al . Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus.  Gastrointest Endosc. 2000;  51 560-568
• 21 Voutilainen M, Farkkila M, Juhola M. et al . Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group.  Am J Gastroenterol. 1999;  94 913-918
• 22 Spechler S J, Zeroogian J M, Antonioli D A. et al . Prevalence of metaplasia at the gastro-oesophageal junction.  Lancet. 1994;  334 1533-1536
• 23 Hackelsberger A, Gunther T, Schultze V. et al . Intestinal metaplasia at the gastroesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?.  Gut. 1998;  43 17-21
• 24 Sharma P. Recent advances in Barrett’s esophagus: short-segment Barrett’s esophagus and cardia intestinal metaplasia.  Semin Gastrointest Dis. 1999;  10 93-102
• 25 Glickman J N, Shahsafaei A, Odze R D. Mucin core peptide expression can help differentiate Barrett’s esophagus from intestinal metaplasia of the stomach.  Am J Surg Pathol. 2003;  27 1357-1365
• 26 Ormsby A H, Vaezi M F, Richter J E. et al . Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett’s esophagus.  Gastroenterology. 2000;  119 683-690
• 27 Phillips R W, Frierson H F Jr, Moskaluk C. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.  Am J Surg Pathol. 2003;  27 1442-1447
• 28 Weston A P, Krmpotich P T, Cherian R. et al . Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus.  Am J Gastroenterol. 1997;  92 407-413
• 29 Chandrasoma P T, Der R, Ma Y. et al . Histology of the gastroesophageal junction: an autopsy study.  Am J Surg Pathol. 2000;  24 402-409